[18 months' tracking of a drug surveillance survey in dermatology. Methodological evaluation at 30 months].
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000009:adverse effects*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002317:Cardiovascular Agents / Q000009:adverse effects*; D003873:Dermatitis, Exfoliative / Q000139:chemically induced; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011358:Product Surveillance, Postmarketing; D011693:Purpura / Q000139:chemically induced
D000890:Anti-Infective Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002317:Cardiovascular Agents
Poursuite sur 18 mois d'une enquête de pharmacovigilance en dermatologie. Bilan méthodologique à 30 mois.